Audio

Community Oncology Podcast - Erwinia asparaginase for acute lymphoblastic leukemia

Publish date: May 31, 2012
By
Dr David H. Henry

 

Join Community Oncology Editor-in Chief Dr David H. Henry for an audio tour of the May issue, featuring "Erwinia asparaginase for acute lymphoblastic leukemia in children with hypersensitivity to E. coli-derived asparaginase" and "Creating a community-based, patient-centered cancer survivorship program."

Recommended Reading

Surgeon General: Decline in Tobacco Use Stalls
MDedge Hematology and Oncology
Infants Left Out of Survival Gains in Childhood Leukemia
MDedge Hematology and Oncology
NCCN Cancer Guidelines Focus on Adolescent, Young Adult Needs
MDedge Hematology and Oncology
NCCN: Stratify Acute Lymphoblastic Leukemia Patients by Age
MDedge Hematology and Oncology
In the Pipeline: Immunotherapy Slows Childhood Gliomas
MDedge Hematology and Oncology
Consider Chemotherapy after Induction Failure for Childhood Leukemia
MDedge Hematology and Oncology
Cixutumumab With Temsirolimus Slows Ewing's Sarcoma
MDedge Hematology and Oncology
Propranolol Considered Standard of Care for Infantile Hemangiomas
MDedge Hematology and Oncology
Crizotinib Shows Strong Activity Against ALK-Driven Pediatric Cancers
MDedge Hematology and Oncology
Chlorhexidine-Resistant S. aureus Infections on the Rise
MDedge Hematology and Oncology